Perrigo Company plc

NYSE PRGO

Perrigo Company plc Net Income for the year ending December 31, 2023: USD -12.70 M

Perrigo Company plc Net Income is USD -12.70 M for the year ending December 31, 2023, a 90.30% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
  • Perrigo Company plc Net Income for the year ending December 31, 2022 was USD -130.90 M, a 0.00% change year over year.
  • Perrigo Company plc Net Income for the year ending December 31, 2021 was USD -130.90 M, a 19.50% change year over year.
  • Perrigo Company plc Net Income for the year ending December 31, 2020 was USD -162.60 M, a -211.29% change year over year.
  • Perrigo Company plc Net Income for the year ending December 31, 2019 was USD 146.10 M, a 11.53% change year over year.
Key data
Date Net Income EPS (Diluted) Shares (Diluted, Weighted) Net Income Margin
Market news
Loading...
NYSE: PRGO

Perrigo Company plc

CEO Mr. Patrick Lockwood-Taylor
IPO Date Dec. 17, 1991
Location Ireland
Headquarters The Sharp Building
Employees 9,140
Sector Consumer Staples
Industries
Description

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Similar companies

PCRX

Pacira BioSciences, Inc.

USD 20.55

-2.74%

PBH

Prestige Consumer Healthcare Inc.

USD 75.78

1.54%

ANIP

ANI Pharmaceuticals, Inc.

USD 54.16

0.43%

PAHC

Phibro Animal Health Corporation

USD 20.28

0.05%

ELAN

Elanco Animal Health Incorporated

USD 11.70

0.00%

COLL

Collegium Pharmaceutical, Inc.

USD 33.18

-1.80%

AMPH

Amphastar Pharmaceuticals, Inc.

USD 38.48

1.48%

StockViz Staff

January 15, 2025

Any question? Send us an email